TLR4 and breast carcinoma: Paclitaxel-induced TLR4 signaling in murine and human breast cancer cells results in the production of the proinflammatory cytokines IL-1ß and IL-6, which promotes the expansion of MDSCs in the bone marrow and spleen as well as their recruitment to the TME (36).